Emerging Concepts Linking Obesity with the Hallmarks of Cancer

Trends in Endocrinology and Metabolism

Volumn 28, Issue 1, 2017, Pages 46-62

  Donohoe, Claire L ^a   Lysaght, Joanne ^a   O'Sullivan, Jacintha ^a   Reynolds, John V ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

cancer; cellular instability; inflammation; microenvironment; obesity

Indexed keywords

AROMATASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEPTIN; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTAGLANDIN E2; PROTEIN P53;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANGIOGENESIS; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; NEOPLASM; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; STROMA; STROMA CELL; TUMOR MICROENVIRONMENT; ADIPOCYTE; ANIMAL; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY;

EID: 84994908897     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2016.08.004     Document Type: Review

References (125)

1. 1 Renehan, A.G., et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371 (2008), 569–578.
2. 2 Bhaskaran, K., et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 384 (2014), 755–765.
3. 3 Arnold, M., et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 16 (2015), 36–46.
4. 4 Ng, M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
5. 2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med., 11, 2014, e1001673.
6. 6 Moore, L.L., et al. Metabolic health reduces risk of obesity-related cancer in Framingham study adults. Cancer Epidemiol. Biomarkers Prev. 23 (2014), 2057–2065.
7. 7 Hanahan, D., Weinberg, R.A., The hallmarks of cancer. Cell 100 (2000), 57–70.
8. 8 Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
9. 9 Berryhill, G.E., et al. Diet-induced metabolic change induces estrogen-independent allometric mammary growth. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 16294–16299.
10. 10 Kim, J., et al. Estrogen deprivation and excess energy supply accelerate 7, 12-dimethylbenz (a) anthracene-induced mammary tumor growth in C3H/HeN mice. Nutr. Res. Pract. 9 (2015), 628–636.
11. 11 Cowen, S., et al. High-fat, high-calorie diet enhances mammary carcinogenesis and local inflammation in MMTV-PyMT mouse model of breast cancer. Cancers 7 (2015), 1125–1142.
12. 12 Gahete, M.D., et al. Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice. Carcinogenesis 35 (2014), 2467–2473.
13. 13 Sundaram, S., et al. Obesity-mediated regulation of HGF/c-Met is associated with reduced basal-like breast cancer latency in parous mice. PLoS One, 9, 2014, e111394.
14. 14 Subbaramaiah, K., et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev. Res. 4 (2011), 329–346.
15. 15 Ford, N.A., et al. Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator MicroRNA-504. PLoS One, 8, 2013, e68089.
16. 16 Bhardwaj, P., et al. Caloric restriction reverses obesity-induced mammary gland inflammation in mice. Cancer Prev. Res. 6 (2013), 282–289.
17. 17 Nogueira, L.M., et al. Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1. Cancer Med. 1 (2012), 275–288.
18. 18 Ford, N.A., et al. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression. Endocr. Relat. Cancer 20 (2013), 39–51.
19. 19 Chen, C-T., et al. Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer. Mol. Cancer Ther. 11 (2012), 2212–2221.
20. 20 De Angel, R.E., et al. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001. Mol. Carcinog. 52 (2013), 446–458.
21. 21 Stark, A.P., et al. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice. Surgery 158 (2015), 1564–1572.
22. 22 Philip, B., et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology 145 (2013), 1449–1458.
23. 23 Dawson, D.W., et al. High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model. Cancer Prev. Res. 6 (2013), 1064–1073.
24. 24 Hertzer, K.M., et al. Robust early inflammation of the peripancreatic visceral adipose tissue during diet-induced obesity in the KrasG12D model of pancreatic cancer. Pancreas 45 (2016), 458–465.
25. 25 Harvey, A.E., et al. Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner. PLoS One, 9, 2014, e94151.
26. 26 Lashinger, L.M., et al. Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer. Cancer Prev. Res. 4 (2011), 1041–1051.
27. 27 Lashinger, L.M., et al. Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2–driven pancreatic neoplasia. Cancer Prev. Res. 4 (2011), 1030–1040.
28. 28 Park, J.W., et al. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model. Endocr. Relat. Cancer 23 (2016), 53–63.
29. 29 Kim, W.G., et al. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology 154 (2013), 2936–2947.
30. 30 Li, H-J., et al. Diet-induced obesity promotes murine gastric cancer growth through a nampt/sirt1/c-myc positive feedback loop. Oncol. Rep. 30 (2013), 2153–2160.
31. 31 James, B.R., et al. Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J. Immunol. 189 (2012), 1311–1321.
32. 32 Ericksen, R.E., et al. Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response. Gut 63 (2013), 385–394.
33. 33 Li, H-J., et al. Diet-induced obesity potentiates the growth of gastric cancer in mice. Exp. Ther. Med. 4 (2012), 615–620.
34. 34 Hale, M., et al. Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2. PLoS One, 10, 2015, e0118784.
35. 35 Olivo-Marston, S.E., et al. Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression. PLoS One, 9, 2014, e94765.
36. 36 DeClercq, V., et al. Obesity promotes colonic stem cell expansion during cancer initiation. Cancer Lett. 369 (2015), 336–343.
37. 37 Rondini, E.A., et al. Energy balance modulates colon tumor growth: interactive roles of insulin and estrogen. Mol. Carcinog. 50 (2011), 370–382.
38. 38 Endo, H., et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60 (2011), 1363–1371.
39. 39 Day, S.D., et al. Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer. Cytokine 64 (2013), 454–462.
40. 40 Tuominen, I., et al. Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice. PLoS One, 8, 2013, e60939.
41. 41 Harvey, A.E., et al. Decreased systemic IGF-1 in response to calorie restriction modulates murine tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression. Mol. Carcinog. 52 (2013), 997–1006.
42. 42 Padidar, S., et al. Leptin up-regulates pro-inflammatory cytokines in discrete cells within mouse colon. J. Cell. Physiol. 226 (2011), 2123–2130.
43. 43 Liu, Z., et al. Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J. Nutr. Biochem. 23 (2012), 1207–1213.
44. 44 Kumar, D.B.U., et al. TLR4 signaling via NANOG cooperates with STAT3 to activate Twist1 and promote formation of tumor-initiating stem-like cells in livers of mice. Gastroenterology 150 (2016), 707–719.
45. 45 Stauffer, J.K., et al. Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors. Cancer Res. 71 (2011), 2718–2727.
46. + T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26 (2014), 549–564.
47. 47 West, D.B., et al. Dietary obesity in nine inbred mouse strains. Am. J. Physiol. Regul. Integr. Comp. Physiol. 262 (1992), R1025–R1032.
48. 48 Cheon, D-J., Orsulic, S., Mouse models of cancer. Annu. Rev. Pathol. 6 (2011), 95–119.
49. 49 Frese, K.K., Tuveson, D.A., Maximizing mouse cancer models. Nat. Rev. Cancer 7 (2007), 654–658.
50. 50 Paik, S., et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J. Clin. Oncol. 24 (2006), 3726–3734.
51. 51 Cancer Genome Atlas Network, et al. Comprehensive molecular portraits of human breast tumours. Nature 490 (2012), 61–70.
52. 52 Creighton, C.J., et al. A gene transcription signature of obesity in breast cancer. Breast Cancer Res. Treat. 132 (2012), 993–1000.
53. 53 Pilie, P.G., et al. Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data. Cancer Epidemiol. Biomarkers Prev. 20 (2011), 476–482.
54. 54 Berg, A., et al. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget, 6, 2015, 1327.
55. 55 Westin, S.N., et al. PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. Mol. Oncol. 9 (2015), 1694–1703.
56. 56 Thrift, A.P., et al. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J. Natl. Cancer Inst., 106, 2014, dju252.
57. 57 Medzhitov, R., Origin and physiological roles of inflammation. Nature 454 (2008), 428–435.
58. 58 Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420 (2002), 860–867.
59. 59 Elinav, E., et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13 (2013), 759–771.
60. 60 O'Sullivan, K.E., et al. Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?. J. Gastrointest. Cancer 45 (2014), 1–11.
61. 61 Chien, Y., et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25 (2011), 2125–2136.
62. 62 Huber, M.A., et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114 (2004), 569–581.
63. 63 Rokavec, M., et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest. 124 (2014), 1853–1867.
64. 64 Exley, M.A., et al. Interplay between the immune system and adipose tissue in obesity. J. Endocrinol. 223 (2014), R41–R48.
65. 65 Weisberg, S.P., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003), 1796–1808.
66. 66 Lysaght, J., et al. Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett. 312 (2011), 62–72.
67. 67 Kitahara, C.M., et al. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance. Cancer Epidemiol. Biomarkers Prev. 23 (2014), 2840–2849.
68. 68 Sturtz, L.A., et al. Gene expression differences in adipose tissue associated with breast tumorigenesis. Adipocyte 3 (2014), 107–114.
69. 69 Ribeiro, R., et al. Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue. BMC Med., 10, 2012, 1.
70. 70 Ribeiro, R.J., et al. Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile. Cell. Physiol. Biochem. 29 (2012), 233–240.
71. 71 Allott, E.H., et al. Elevated tumor expression of PAI-1 and SNAI2 in obese esophageal adenocarcinoma patients and impact on prognosis. Clin. Transl. Gastroenterol., 3, 2012, e12.
72. 72 Amor, S., et al. Peritumoral adipose tissue as a source of inflammatory and angiogenic factors in colorectal cancer. Int. J. Colorectal Dis. 31 (2016), 365–375.
73. 73 Liu, Y., et al. Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages. Cancer Res. 75 (2015), 5046–5057.
74. 74 Arendt, L.M., et al. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res. 73 (2013), 6080–6093.
75. 75 Santander, A.M., et al. Paracrine interactions between adipocytes and tumor cells recruit and modify macrophages to the mammary tumor microenvironment: the role of obesity and inflammation in breast adipose tissue. Cancers 7 (2015), 143–178.
76. 76 Mayi, T.H., et al. Human adipose tissue macrophages display activation of cancer-related pathways. J. Biol. Chem. 287 (2012), 21904–21913.
77. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15 (2009), 914–920.
78. + cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39 (2009), 1893–1901.
79. 79 Conroy, M.J., et al. The microenvironment of visceral adipose tissue and liver alter natural killer cell viability and function. J. Leukoc. Biol., 2016, 10.1189/jlb.5AB1115-493RR Published online June 30, 2016.
80. 80 Zhang, Y., et al. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 69 (2009), 5259–5266.
81. 81 Zhang, T., et al. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nat. Commun., 7, 2016, 11674.
82. 82 Greenberg, J.I., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456 (2008), 809–813.
83. 83 Zhang, Y., et al. Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Res. 72 (2012), 5198–5208.
84. 84 Zhang, Y., et al. Stromal cells derived from visceral and obese adipose tissue promote growth of ovarian cancers. PLoS One, 10, 2015, e0136361.
85. 85 Ito, Y., et al. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity. Prostate 75 (2015), 1009–1019.
86. 86 Pasarica, M., et al. Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. Metab. 94 (2009), 5155–5162.
87. 87 Park, J., Scherer, P.E., Adipocyte-derived endotrophin promotes malignant tumor progression. J. Clin. Invest., 122, 2012, 4243.
88. 88 Frantz, C., et al. The extracellular matrix at a glance. J. Cell Sci. 123 (2010), 4195–4200.
89. 89 Lu, P., et al. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196 (2012), 395–406.
90. 90 Hynes, R.O., The extracellular matrix: not just pretty fibrils. Science 326 (2009), 1216–1219.
91. 91 Seo, B.R., et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci. Transl. Med., 7, 2015, 301ra130.
92. 92 Bulun, S.E., et al. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol. Metab. 23 (2012), 83–89.
93. 93 Subbaramaiah, K., et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov. 2 (2012), 356–365.
94. 94 Sofi, M., et al. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res. Treat. 79 (2003), 399–407.
95. 95 Wang, X., et al. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer. Cancer Res. 75 (2015), 645–655.
96. 96 Samarajeewa, N.U., et al. HIF-1a stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma. Breast Cancer Res., 15, 2013, R30.
97. 97 Giles, E.D., et al. Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res. 72 (2012), 6490–6501.
98. 98 Garofalo, C., Surmacz, E., Leptin and cancer. J. Cell. Physiol. 207 (2006), 12–22.
99. 99 La Cava, A., Matarese, G., The weight of leptin in immunity. Nat. Rev. Immunol. 4 (2004), 371–379.
100. 100 Catalano, S., et al. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor α in MCF-7 cells. J. Biol. Chem. 279 (2004), 19908–19915.
101. 101 Strong, A.L., et al. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Res., 15, 2013, R102.
102. 102 Kasiappan, R., et al. Vitamin D suppresses leptin stimulation of cancer growth through microRNA. Cancer Res. 74 (2014), 6194–6204.
103. 103 Esper, R.M., et al. Leptin and adiponectin modulate the self-renewal of normal human breast epithelial stem cells. Cancer Prev. Res. 8 (2015), 1174–1183.
104. 104 Zheng, Q., et al. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr. Relat. Cancer 20 (2013), 797–808.
105. 105 Giordano, C., et al. Leptin as a mediator of tumor–stromal interactions promotes breast cancer stem cell activity. Oncotarget, 7, 2016, 1262.
106. 106 Chang, C.C., et al. Leptin-STAT3-G9a signaling promotes obesity-mediated breast cancer progression. Cancer Res. 75 (2015), 2375–2386.
107. 107 Kato, S., et al. Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women. Oncotarget 6 (2015), 21100–21119.
108. 108 Papanikolaou, V., et al. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. Cell. Oncol. 38 (2015), 155–164.
109. 109 Alshaker, H., et al. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, Janus kinase 2-independent pathway. Breast Cancer Res., 16, 2014, 426.
110. 110 Yao-Borengasser, A., et al. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells. Oncol. Rep. 33 (2015), 2689–2694.
111. 111 Strong, A.L., et al. Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res. 17 (2015), 1–16.
112. 112 Negrini, S., et al. Genomic instability – an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11 (2010), 220–228.
113. 113 Hoffmeister, M., et al. Body mass index and microsatellite instability in colorectal cancer: a population-based study. Cancer Epidemiol. Biomarkers Prev. 22 (2013), 2303–2311.
114. 114 Amankwah, E.K., et al. Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype. Am. J. Epidemiol. 177 (2013), 1378–1387.
115. 115 Tafurt-Cardona, Y., et al. High frequency of chromosome aberrations observed in lymphocytes in postmenopausal obese women. Biomédica 32 (2012), 344–354.
116. 116 Mongan, A., et al. Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma. Clin. Transl. Oncol. 18 (2016), 632–640.
117. 117 Seyfried, T.N., Shelton, L.M., Cancer as a metabolic disease. Nutr. Metab., 7, 2010, 1.
118. 118 Galluzzi, L., et al. Mitochondrial gateways to cancer. Mol. Aspects Med. 31 (2010), 1–20.
119. 119 Lynam-Lennon, N., et al. Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma. BMC Cancer, 14, 2014, 907.
120. 120 Ley, R.E., et al. Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
121. 121 Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
122. 122 Cani, P.D., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
123. 123 Ridlon, J.M., et al. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47 (2006), 241–259.
124. 124 Kuilman, T., et al. The essence of senescence. Genes Dev. 24 (2010), 2463–2479.
125. 125 Yoshimoto, S., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499 (2013), 97–101.